We serve Chemical Name:4-(3-Methylbutanoyl)phenylboronic acid CAS:1256346-29-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(3-Methylbutanoyl)phenylboronic acid
CAS.NO:1256346-29-8
Synonyms:[4-(3-Methylbutanoyl)phenyl]boronic acid
Molecular Formula:C11H15BO3
Molecular Weight:206.04600
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:57.53000
Exact Mass:206.11100
LogP:0.59520
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like [4-(3-Methylbutanoyl)phenyl]boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[4-(3-Methylbutanoyl)phenyl]boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[4-(3-Methylbutanoyl)phenyl]boronic acid Use and application,[4-(3-Methylbutanoyl)phenyl]boronic acid technical grade,usp/ep/jp grade.
Related News: An inherent advantage of using enzymes for synthetic chemistry is that they increase regio-, enantio-, and stereoselectivity for more efficient conversion of substrate to product. N-OCTYLMETHYLDIETHOXYSILANE manufacturers An inherent advantage of using enzymes for synthetic chemistry is that they increase regio-, enantio-, and stereoselectivity for more efficient conversion of substrate to product. Tetrachlorosilane suppliers But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals. Tetra(methylisobutylketoxime)silane vendor & factory The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. ,The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities.
